Compounds > 2-(1-(2-(1-methylpyrrolidino)ethyl)-1h-indol-3-yl)maleimide
Page last updated: 2024-10-23

2-(1-(2-(1-methylpyrrolidino)ethyl)-1h-indol-3-yl)maleimide and Breast Cancer

2-(1-(2-(1-methylpyrrolidino)ethyl)-1h-indol-3-yl)maleimide has been researched along with Breast Cancer in 1 studies

bisindolylmaleimide II: protein kinase C inhibitor; see also bisindolylmaleimide I

Research Excerpts

ExcerptRelevanceReference
"PKC may be therefore a target for breast cancer treatment."1.31Protein kinase C involvement in proliferation and survival of breast cancer cells. ( Dabrowska, M; Dziecioł, J; Jarzabek, K; Laudański, P; Wołczyński, S, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jarzabek, K1
Laudański, P1
Dziecioł, J1
Dabrowska, M1
Wołczyński, S1

Other Studies

1 other study available for 2-(1-(2-(1-methylpyrrolidino)ethyl)-1h-indol-3-yl)maleimide and Breast Cancer

ArticleYear
Protein kinase C involvement in proliferation and survival of breast cancer cells.
    Folia histochemica et cytobiologica, 2002, Volume: 40, Issue:2

    Topics: Apoptosis; Breast Neoplasms; Cell Division; Cell Line; Cell Survival; Enzyme Activators; Enzyme Inhi

2002